Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2024-08-19 00:00:00 ET · period of report 2024-08-16 · accession 0001396814-24-000117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-19 | 2024-08-16 | PCRX | Brege Laura | Dir | P - Purchase | $12.81 | +1,000 | 17.6K | +6% | +$12.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-16 | P | A | 1,000 | $12.81 | 17,552 | D | — | — |